Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Due to the biological heterogeneity, 60%–70% of patients with major depressive disorder (MDD) do not respond to or achieve remission from first‐line antidepressants. Predicting neuroimaging biomarkers for early antidepressant treatment could guide initial antidepressant therapy.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To assess for neuroimaging biomarkers for antidepressant selection in early antidepressant treatment.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Prospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Subjects</h3><p>A total of 85 MDD patients from the major site and 33 MDD patients from an out‐of‐sample test site.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>A 3.0 T, T1‐weighted imaging using a magnetization‐prepared rapid acquisition gradient‐echo sequence and diffusion tensor imaging (DTI) using an echo‐planar sequence.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Baseline DTI data of patients who achieved early improvement after 2‐weeks of antidepressant treatment (selective serotonin reuptake inhibitors [SSRI] or serotonin‐norepinephrine reuptake inhibitors [SNRI]) were analyzed. An ensemble model was constructed using data from the major site and then applied to assess the early response of patients at the out‐of‐sample test site.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Support vector machine combined with leave‐one‐out cross‐validation were applied to construct the whole model from individual base models from different brain regions. Discriminative biomarkers were evaluated by calculating the changes in sensitivity and specificity obtained when removing a single base model from the whole model, the base model being removed changing in each run.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Training performance over MDD patients at the major site achieved 75% accuracy while performance with accuracy of 70% was achieved in the out‐of‐sample test site. Assessing sensitivity and specificity changes following the removal of single base models from the prominent model highlighted the functions of two neural circuitries: SSRI‐related emotion regulation circuitry, centered on the hippocampus (sensitivity changes: 10%) and amygdala (sensitivity changes: 11%); and SNRI‐related emotion and reward circuitry, centered on the putamen (specificity changes: 8%) and orbital part of superior frontal gyrus (specificity changes: 12%).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>These findings support future research on clinical antidepressant selection for MDD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Evidence Level</h3><p>1</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy</h3><p>Stage 2</p></section>

Distinctive Pretreatment Features of Bilateral Nucleus Accumbens Networks Predict Early Response to Antidepressants in Major Depressive Disorder

Abnormal functional connectivity within the reward network: a potential neuroimaging endophenotype of bipolar disorder.

Predict Value of Functional Topological Features for Early Response to Antidepressant Treatment in Major Depressive Disorder

Sub-hubs of Baseline Functional Brain Networks Are Related to Early Improvement Following Two-Week Pharmacological Therapy for Major Depressive Disorder.

Distinct Features of Cerebral Blood Flow and Spontaneous Neural Activity as Integrated Predictors of Early Response to Antidepressants.

Divergent Topological Architecture of the Default Mode Network As a Pretreatment Predictor of Early Antidepressant Response in Major Depressive Disorder

Reduced Nucleus Accumbens Functional Connectivity in Reward Network and Default Mode Network in Patients with Recurrent Major Depressive Disorder.

Pretreatment predictors of early response revealed by quantitative cerebral blood flow in major depressive disorder

Identification of first-episode unmedicated major depressive disorder using pretreatment features of dominant coactivation patterns.

Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression

Increased Temporal Variability of Striatum Region Facilitating the Early Antidepressant Response in Patients with Major Depressive Disorder

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

Differentiation of Transformed Bipolar Disorder from Unipolar Depression by Resting-State Functional Connectivity Within Reward Circuit.

Baseline Patterns of Resting Functional Connectivity Within Posterior Default-Mode Intranetwork Associated with Remission to Antidepressants in Major Depressive Disorder

Contribution of resting-state functional connectivity of the subgenual anterior cingulate to prediction of antidepressant efficacy in patients with major depressive disorder

Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study

Study on Functional Connectivity Between the Subgenual Anterior Cingulate Cortes and Limbic Cortices in Predicting the Efficacy of Early Antidepressant Treatment Outcome

Correlation Between Functional Connectivity of the Precuneus and Early Efficacy to Antidepressant Treatment in Patients of Major Depressive Disorder

Prognostic value of imbalanced interhemispheric functional coordination in early therapeutic efficacy in major depressive disorder

Electrophysiological predictors of early response to antidepressants in major depressive disorder

Functional Connectivity of the Hippocampus in Predicting Early Antidepressant Efficacy in Patients with Major Depressive Disorder.